<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">fcmedicine</journal-id><journal-title-group><journal-title xml:lang="ru">Фундаментальная и клиническая медицина</journal-title><trans-title-group xml:lang="en"><trans-title>Fundamental and Clinical Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2500-0764</issn><issn pub-type="epub">2542-0941</issn><publisher><publisher-name>КемГМУ</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">fcmedicine-74</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>ПЕРИВАСКУЛЯРНОЙ АСТРОГЛИИ И CD133+ КЛЕТОК-ПРЕДШЕСТВЕННИКОВ ЭНДОТЕЛИОЦИТОВ ПРИ МОДЕЛИРОВАНИИ БОЛЕЗНИ АЛЬЦГЕЙМЕРА У МЫШЕЙ</article-title><trans-title-group xml:lang="en"><trans-title>PRO-INFLAMMATORY PHENOTYPE OF PERIVASCULAR ASTROCYTES AND CD133+ ENDO-THELIAL PROGENITOR CELLS IN MURINE MODEL OF ALZHEIMER’S DISEASE</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Черных</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Chernykh</surname><given-names>ANATOLIY I.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Комлева</surname><given-names>Ю. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Komleva</surname><given-names>YULIYA K.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Горина</surname><given-names>Я. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gorina</surname><given-names>YANA V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лопатина</surname><given-names>О. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Lopatina</surname><given-names>OLGA L.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пащенко</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Paschenko</surname><given-names>SVETLANA I.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Салмина</surname><given-names>А. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Salmina</surname><given-names>ALLA B.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>НИИ молекулярной медицины и патобиохимии, ФГБОУ ВО «Красноярский государственный медицинский университет им. проф. В.Ф. Войно-Ясенецкого» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute of Molecular Medicine and Pathological Biochemistry, Voyno-Yasenetsky Krasnoyarsk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>НИИ молекулярной медицины и патобиохимии, ФГБОУ ВО «Красноярский государственный медицинский университет им. проф. В.Ф. Войно-Ясенецкого» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute of Molecular Medicine and Pathological Biochemistry, Voyno-Yasenetsky Krasnoyarsk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБОУ ВО «Красноярский государственный медицинский университет имени профессора В.Ф. Войно-Ясенецкого» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Department of Biological, Medical, Pharmaceutical and Toxicological Chemistry, Voyno-Yasenetsky Krasnoyarsk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>30</day><month>03</month><year>2018</year></pub-date><volume>3</volume><issue>1</issue><fpage>6</fpage><lpage>15</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Черных А.И., Комлева Ю.К., Горина  Я.В., Лопатина О.Л., Пащенко  С.И., Салмина А.Б., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Черных А.И., Комлева Ю.К., Горина  Я.В., Лопатина О.Л., Пащенко  С.И., Салмина А.Б.</copyright-holder><copyright-holder xml:lang="en">Chernykh A.I., Komleva Y.K., Gorina Y.V., Lopatina O.L., Paschenko S.I., Salmina A.B.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://fcm.kemsmu.ru/jour/article/view/74">https://fcm.kemsmu.ru/jour/article/view/74</self-uri><abstract><p>Цель.  Изучить  экспрессию  NLRP3  в  периваскулярной  астроглии  и  CD133+  эндотелиальных клетках-предшественниках при амилоид-индуцированной нейродегенерации. Материалы и методы.  Эксперименты  выполнены на мышах мужского пола линии CD1 (4  месяцев,  весом  25-30  г). Мышам  экспериментальной группы введен Aβ1-42 в гиппокамп головного  мозга.  Через  10  дней  после  инъекции  провели иммуногистохимическую оценку экспрессии NLRP3 инфламмасом в S100beta и CD133+ клетках методом визуализации конфокальной микроскопии. Определили коэффициент корреляции Пирсона и коэффициент перекрытия по Manders (overlap coefficient). Результаты.  Определено  увеличение  экспрессии S100betа-позитивных клеток при введении  бета-амилоида  в  гиппокамп  животных. При  оценивании  колокализации  S100beta/NL-RP3 выявлена выраженная положительная корреляция  двух  маркеров  S100beta  и  NLRP3  в клетках зубчатой извилины обеих групп животных. При иммуногистохимическом исследовании CD133+ клеток-предшественниц не зафиксировано статистически значимых отличий при моделировании нейродегенерации и при проведении  ложной  операции,  однако  наблюдалась тенденция  к  снижению  экспрессии  данного маркера при введении олигомеров бета-амилоида. Тем не менее, при моделировании амилоид-индуцированной нейродегенерации отмечается статистически значимое увеличение колокализации CD133/NLRP3. Заключение.  При  моделировании  болезни Альцгеймера отмечается эффект активации глии  с экспрессией  S100beta.  Увеличение  экспрессии  S100beta  может  свидетельствовать  о том, что при экспериментальной болезни Альцгеймера  S100beta-иммунопозитивные  (протоплазматические,  ассоциированные  с  нейроваскулярной  единицей)  астроциты  в  пределах нейрогенных  ниш  реагируют  на  нейротоксическое  действие  олигомеров  бета-амилоида. По  данным  иммуногистохимического  анализа было показано, что развитие воспаления в ткани головного мозга при нейротоксическом дейcтвии  бета-амилоида  связано  с  формированием  NLRP3-инфламмасом  в  нейрогенной  нише головного  мозга,  что  в  конечном  итоге  может приводить  к  нарушению  процессов  синаптогенеза,  нейрогенеза  и  ангиогенеза,  ассоциированных  с  репарацией  или  реализацией  когнитивных функций. Экспрессия  инфламмасом NLRP3  в  CD133+  клетках-предшественниках эндотелиальных клеток увеличивается при моделировании болезни Альцгеймера. Такой провоспалительный фенотип клеток, по всей видимости, необходим для формирования сложного самоактивирующегося  порочного  круга,  способного приводить к дальнейшей дисфункции нейроваскулярной единицы.</p></abstract><trans-abstract xml:lang="en"><p>Aim. To study the expression of NLRP3 in perivascular astrocytes and CD133+ endothelial progenitor cells in mice with amyloid-induced neurodegeneration.Materials and Methods. Ten days following intrahippocampal injection of Aβ1-42, male CD1 mice (4 months, weight 25-30 g) were sacrificed with the further immunohistochemical examination of the NLRP3 expression in S100 beta + and CD133+ cells using confocal microscopy. Results.  We detected an increased number of S100beta + cells upon the administration of β-amyloid to the hippocampus. Moreover, a strong colocalization of S100beta and NLRP3 in the dentate gyrus of both groups was revealed indicative of neuroinflammation. CD133 immunostaining did not identify any differences in CD133+ cells between mice with Alzheimer’s disease and sham-treated mice, yet there was a notable reduction in CD133+ cell count after intrahippocampal injection of β-amyloid. Conclusion.  Neuroinflammation  induced  by β-amyloid is associated with the formation of NL-RP3  inflammasomes  and  decreased  neovascularization capacity.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>периваскулярная  астроглия</kwd><kwd>инфламмасомы NLRP3</kwd><kwd>клетки-предшественники эндотелиоцитов</kwd><kwd>моделирование болезни Альцгеймера у мышей</kwd><kwd>perivascular astrocytes</kwd><kwd>NLRP3 inflammasomes</kwd><kwd>endothelial progenitor cells</kwd><kwd>Alzheimer's disease</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Selkoe DJ. Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev. 2001; 81 (2): 741-766.</mixed-citation><mixed-citation xml:lang="en">Selkoe DJ. Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev. 2001; 81 (2): 741-766.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Jorge G, Fossati S, Rostagno A. Amyloidosis Associated with Cerebral Amyloid Angiopathy: Cell Signaling Pathways Elicited in Cerebral Endothelial Cells. J Alzheimers Dis. 2014; 42 (03): 167-176.</mixed-citation><mixed-citation xml:lang="en">Jorge G, Fossati S, Rostagno A. Amyloidosis Associated with Cerebral Amyloid Angiopathy: Cell Signaling Pathways Elicited in Cerebral Endothelial Cells. J Alzheimers Dis. 2014; 42 (03): 167-176.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Yamazaki Y, Kanekiyo T. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease. Int J Mol Sci. 2017; 18 (9). pii: E1965.</mixed-citation><mixed-citation xml:lang="en">Yamazaki Y, Kanekiyo T. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease. Int J Mol Sci. 2017; 18 (9). pii: E1965.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hall JR, Wiechmann AR., Johnson LA, Edwards M, Barber RC, Winter AS, et al. Biomarkers of Vascular Risk, Systemic Inflammation and Microvascular Pathology and Neuropsychiatric Symptoms in Alzheimer’s Disease. J Alzheimers Dis. 2013; 35 (2): 363-371.</mixed-citation><mixed-citation xml:lang="en">Hall JR, Wiechmann AR., Johnson LA, Edwards M, Barber RC, Winter AS, et al. Biomarkers of Vascular Risk, Systemic Inflammation and Microvascular Pathology and Neuropsychiatric Symptoms in Alzheimer’s Disease. J Alzheimers Dis. 2013; 35 (2): 363-371.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Komleva YuK, Kuvacheva NV, Malinocskaya NA, Gorina YaV, Lopatina OL, Teplyashina EA, et al. Regenerative potential of the brain: Composition and forming of regulatory microenvironment in neurogenic niches. Human Physiology. 2016; 42 (8): 865-873.</mixed-citation><mixed-citation xml:lang="en">Komleva YuK, Kuvacheva NV, Malinocskaya NA, Gorina YaV, Lopatina OL, Teplyashina EA, et al. Regenerative potential of the brain: Composition and forming of regulatory microenvironment in neurogenic niches. Human Physiology. 2016; 42 (8): 865-873.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Salmina AB, Komleva YuK, Lopatina OL, Kuvacheva NV, Gorina YaV, Panina YuA, et al. Astroglial control of neuroinflammation:TLR3-mediated dsRNA-sensing pathways are in the focus. Rev Neurosci. 2015; 26(2): 143-159.</mixed-citation><mixed-citation xml:lang="en">Salmina AB, Komleva YuK, Lopatina OL, Kuvacheva NV, Gorina YaV, Panina YuA, et al. Astroglial control of neuroinflammation:TLR3-mediated dsRNA-sensing pathways are in the focus. Rev Neurosci. 2015; 26(2): 143-159.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Jo WK, Law AC, Chung SK. The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocognitive disorders. Mol Psychiatry. 2014; 19 (2): 159-167.</mixed-citation><mixed-citation xml:lang="en">Jo WK, Law AC, Chung SK. The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocognitive disorders. Mol Psychiatry. 2014; 19 (2): 159-167.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Gorina R, Font-Nieves M, Márquez-Kisinousky L, Santalucia T, Planas AM. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways. Glia. 2011; 59 (2): 242-255.</mixed-citation><mixed-citation xml:lang="en">Gorina R, Font-Nieves M, Márquez-Kisinousky L, Santalucia T, Planas AM. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways. Glia. 2011; 59 (2): 242-255.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Di Virgilio F. The therapeutic potential of modifying inflammasomes and NOD-like receptors. Pharmacol Rev. 2013; 65 (3): 872-905.</mixed-citation><mixed-citation xml:lang="en">Di Virgilio F. The therapeutic potential of modifying inflammasomes and NOD-like receptors. Pharmacol Rev. 2013; 65 (3): 872-905.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol. 2008; 9 (8): 857-865.</mixed-citation><mixed-citation xml:lang="en">Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol. 2008; 9 (8): 857-865.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">White CS, Lawrence CB, Brough D, Rivers-Auty J. Inflammasomes as therapeutic targets for Alzheimer's disease. Brain Pathol. 2017; 27 (2): 223-234.</mixed-citation><mixed-citation xml:lang="en">White CS, Lawrence CB, Brough D, Rivers-Auty J. Inflammasomes as therapeutic targets for Alzheimer's disease. Brain Pathol. 2017; 27 (2): 223-234.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Горина Я.В., Комлева Ю.К., Лопатина О.Л., Волкова В.В., Герцог Г.Е., Попова Н.Н. и др. Особенности экспрессии молекул-маркеров инсулинорезистентности при экспериментальной болезни Альцгеймера // Проблемы эндокринологии. 2015. №4. С. 43-48</mixed-citation><mixed-citation xml:lang="en">Горина Я.В., Комлева Ю.К., Лопатина О.Л., Волкова В.В., Герцог Г.Е., Попова Н.Н. и др. Особенности экспрессии молекул-маркеров инсулинорезистентности при экспериментальной болезни Альцгеймера // Проблемы эндокринологии. 2015. №4. С. 43-48</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Epelbaum S, Youssef I, Lacor PN, Chaurand P, Duplus E, Brugg B, et al. Acute amnestic encephalopathy in amyloid-β oligomer-injected mice is due to their widespread diffusion in vivo. Neurobiol Aging. 2015; 36 (6): 2043-2052.</mixed-citation><mixed-citation xml:lang="en">Epelbaum S, Youssef I, Lacor PN, Chaurand P, Duplus E, Brugg B, et al. Acute amnestic encephalopathy in amyloid-β oligomer-injected mice is due to their widespread diffusion in vivo. Neurobiol Aging. 2015; 36 (6): 2043-2052.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Paxinos G, Franklin K. The Mouse Brain in Stereotaxic Coordinates, 4th Edition. Imprint: Academic Press. 2012. P. 360.</mixed-citation><mixed-citation xml:lang="en">Paxinos G, Franklin K. The Mouse Brain in Stereotaxic Coordinates, 4th Edition. Imprint: Academic Press. 2012. P. 360.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Zinchuk V, Zinchuk O, Okada T. Quantitative colocalization analysis of multicolor confocal immunofluorescence microscopy images: pushing pixels to explore biological phenomena. Acta Histochem Cytochem. 2007; 40: 101-111</mixed-citation><mixed-citation xml:lang="en">Zinchuk V, Zinchuk O, Okada T. Quantitative colocalization analysis of multicolor confocal immunofluorescence microscopy images: pushing pixels to explore biological phenomena. Acta Histochem Cytochem. 2007; 40: 101-111</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Saresella M, Marventano I, Calabrese E, Piancone F, Rainone V, Gatti A, et al. A complex proinflammatory role for peripheral monocytes in Alzheimer's disease. J Alzheimers Dis. 2014; 38 (2): 403-413.</mixed-citation><mixed-citation xml:lang="en">Saresella M, Marventano I, Calabrese E, Piancone F, Rainone V, Gatti A, et al. A complex proinflammatory role for peripheral monocytes in Alzheimer's disease. J Alzheimers Dis. 2014; 38 (2): 403-413.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Birch AM, Katsouri L, Sastre M. Modulation of inflammation in transgenic models of Alzheimer's disease. J Neuroinflammation. 2014; 11: 25.</mixed-citation><mixed-citation xml:lang="en">Birch AM, Katsouri L, Sastre M. Modulation of inflammation in transgenic models of Alzheimer's disease. J Neuroinflammation. 2014; 11: 25.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Chaves ML, Camozzato AL, Kohler C, Kaye J. Predictors of the progression of dementia severity in brazilian patients with Alzheimer's disease and vascular dementia. Int J Alzheimers Dis. 2010; 2010. pii: 673581</mixed-citation><mixed-citation xml:lang="en">Chaves ML, Camozzato AL, Kohler C, Kaye J. Predictors of the progression of dementia severity in brazilian patients with Alzheimer's disease and vascular dementia. Int J Alzheimers Dis. 2010; 2010. pii: 673581</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Моргун А.В., Малиновская Н.А., Комлева Ю.К., Лопатина О.Л., Кувачева Н.В., Панина Ю.А. и др. Структурная и функциональная гетерогенность астроцитов головного мозга: роль в нейрогенезе и нейровоспалении // Бюллетень сибирской медицины. 2014. №5. С. 138-148</mixed-citation><mixed-citation xml:lang="en">Моргун А.В., Малиновская Н.А., Комлева Ю.К., Лопатина О.Л., Кувачева Н.В., Панина Ю.А. и др. Структурная и функциональная гетерогенность астроцитов головного мозга: роль в нейрогенезе и нейровоспалении // Бюллетень сибирской медицины. 2014. №5. С. 138-148</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">McGeer PL, McGeer EG. The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy. Acta Neuropathol. 2013; 126 (4): 479-497.</mixed-citation><mixed-citation xml:lang="en">McGeer PL, McGeer EG. The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy. Acta Neuropathol. 2013; 126 (4): 479-497.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Heneka MT, O’Banion MK, Terwel D, Kummer MP. Neuroinflammatory processes in Alzheimer’s disease. J Neural Transm. 2010; 117 (8): 919-947.</mixed-citation><mixed-citation xml:lang="en">Heneka MT, O’Banion MK, Terwel D, Kummer MP. Neuroinflammatory processes in Alzheimer’s disease. J Neural Transm. 2010; 117 (8): 919-947.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Lee YJ, Han SB, Nam SY, Oh KW, Hong JT. Inflammation and Alzheimer’s disease. Arch Pharm Res. 2010; 33 (10): 1539-1556.</mixed-citation><mixed-citation xml:lang="en">Lee YJ, Han SB, Nam SY, Oh KW, Hong JT. Inflammation and Alzheimer’s disease. Arch Pharm Res. 2010; 33 (10): 1539-1556.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Terrill-Usery SE, Mohan MJ, Nichols MR. Amyloid-β(1-42) protofibrils stimulate a quantum of secreted IL-1β despite significant intracellular IL-1β accumulation in microglia. Biochim Biophys Acta. 2014; 1842 (11): 2276-2285.</mixed-citation><mixed-citation xml:lang="en">Terrill-Usery SE, Mohan MJ, Nichols MR. Amyloid-β(1-42) protofibrils stimulate a quantum of secreted IL-1β despite significant intracellular IL-1β accumulation in microglia. Biochim Biophys Acta. 2014; 1842 (11): 2276-2285.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Goldmann T, Tay TL, Prinz M. Love and death: microglia, NLRP3 and the Alzheimer's brain. Cell Res. 2013; 23 (5): 595-596.</mixed-citation><mixed-citation xml:lang="en">Goldmann T, Tay TL, Prinz M. Love and death: microglia, NLRP3 and the Alzheimer's brain. Cell Res. 2013; 23 (5): 595-596.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Barateiro A, Afonso V, Santos G, Cerqueira JJ, Brites D, van Horssen J, et al. S100B as a Potential Biomarker and Therapeutic Target in Multiple Sclerosis. Mol Neurobiol. 2016; 53 (6): 3976-3991.</mixed-citation><mixed-citation xml:lang="en">Barateiro A, Afonso V, Santos G, Cerqueira JJ, Brites D, van Horssen J, et al. S100B as a Potential Biomarker and Therapeutic Target in Multiple Sclerosis. Mol Neurobiol. 2016; 53 (6): 3976-3991.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Koh SX, Lee JK. S100B as a marker for brain damage and blood-brain barrier disruption following exercise. Sports Med. 2014; 44 (3): 369-385.</mixed-citation><mixed-citation xml:lang="en">Koh SX, Lee JK. S100B as a marker for brain damage and blood-brain barrier disruption following exercise. Sports Med. 2014; 44 (3): 369-385.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Vukic V, Callaghan D, Walker D, Lue LF, Liu QY, Couraud PO, et al. Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer’s brain is mediated by the JNK-AP1 signaling pathway. Neurobiol Dis. 2009; 34: 95-106.</mixed-citation><mixed-citation xml:lang="en">Vukic V, Callaghan D, Walker D, Lue LF, Liu QY, Couraud PO, et al. Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer’s brain is mediated by the JNK-AP1 signaling pathway. Neurobiol Dis. 2009; 34: 95-106.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Stellos K, Panagiota V, Sachsenmaier S, Trunk T, Straten G, Leyhe T, et al. Increased circulating progenitor cells in Alzheimer's disease patients with moderate to severe dementia: evidence for vascular repair and tissue regeneration? J Alzheimers Dis. 2010; 19 (2): 591-600.</mixed-citation><mixed-citation xml:lang="en">Stellos K, Panagiota V, Sachsenmaier S, Trunk T, Straten G, Leyhe T, et al. Increased circulating progenitor cells in Alzheimer's disease patients with moderate to severe dementia: evidence for vascular repair and tissue regeneration? J Alzheimers Dis. 2010; 19 (2): 591-600.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Akita M, Tanaka K, Matsumoto S, Komatsu K, Fujita K. Detection of the Hematopoietic Stem and Progenitor Cell Marker CD133 during Angiogenesis in Three-Dimensional Collagen Gel Culture. Stem Cells Int. 2013; 2013: 927403.</mixed-citation><mixed-citation xml:lang="en">Akita M, Tanaka K, Matsumoto S, Komatsu K, Fujita K. Detection of the Hematopoietic Stem and Progenitor Cell Marker CD133 during Angiogenesis in Three-Dimensional Collagen Gel Culture. Stem Cells Int. 2013; 2013: 927403.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Deng Y, Han X, Yao Z, Sun Y, Yu J, Cai J, et al. PPARα Agonist Stimulated Angiogenesis by Improving Endothelial Precursor Cell Function Via a NLRP3 Inflammasome Pathway. Cell Physiol Biochem. 2017; 42 (6):2255-2266.</mixed-citation><mixed-citation xml:lang="en">Deng Y, Han X, Yao Z, Sun Y, Yu J, Cai J, et al. PPARα Agonist Stimulated Angiogenesis by Improving Endothelial Precursor Cell Function Via a NLRP3 Inflammasome Pathway. Cell Physiol Biochem. 2017; 42 (6):2255-2266.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Son SM, Song H, Byun J, Park KS, Jang HC, Park YJ, et al. Accumulation of autophagosomes contributes to enhanced amyloidogenic APP processing under insulin-resistant conditions. Autophagy. 2012; 8: 1842-1844.</mixed-citation><mixed-citation xml:lang="en">Son SM, Song H, Byun J, Park KS, Jang HC, Park YJ, et al. Accumulation of autophagosomes contributes to enhanced amyloidogenic APP processing under insulin-resistant conditions. Autophagy. 2012; 8: 1842-1844.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Grammas P. Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer’s disease. J Neuroinflammation. 2011; 8: 26.</mixed-citation><mixed-citation xml:lang="en">Grammas P. Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer’s disease. J Neuroinflammation. 2011; 8: 26.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Wilcock DM, Griffin WS. Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis. J Neuroinflammation. 2013; 10: 84.</mixed-citation><mixed-citation xml:lang="en">Wilcock DM, Griffin WS. Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis. J Neuroinflammation. 2013; 10: 84.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
